相关实验视频
Updated: Jun 20, 2025

07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.1K
食物过敏:历史,定义和治疗方法
1From the Division of Allergy and Immunology, Duke Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina; and.
Journal of food allergy
|July 18, 2024
概括
食物过敏免疫疗法选择,如口服,皮肤上和舌下方法,为严格避免提供了替代方案. 虽然口服免疫疗法已获得批准,但其他方法具有较少副作用的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏研究 研究过敏
- 胃肠病学 胃肠病学
背景情况:
- 食物过敏影响了许多人,需要采取替代疗法来严格避免过敏原.
- 免疫球蛋白E (IgE) 介导的食物过敏是一种严重的健康问题.
- 目前的管理通常依赖于饮食限制,这可能会影响生活质量.
研究的目的:
- 审查和比较IgE介导食物过敏的新兴过敏原特异性免疫疗法选择.
- 评估口服,皮肤上和舌下免疫疗法的疗效和安全性.
- 为临床医生和患者提供有关可用和正在开发的治疗方式的信息.
主要方法:
- 对口服免疫疗法 (OIT),皮肤上免疫疗法 (EPIT) 和舌下免疫疗法 (SLIT) 的临床试验数据的审查.
- 对每个免疫疗法类型的疗效和不良反应概况的分析.
- 治疗结果和患者适应性的比较.
主要成果:
- 口服免疫疗法 (OIT) 显示出强烈的疗效,并获得监管部门的批准,但存在副作用的风险.
- 皮肤上免疫疗法 (EPIT) 和舌下免疫疗法 (SLIT) 显示出适度的疗效,具有更有利的安全性.
- 这些替代免疫疗法可能适合那些不能容忍OIT的患者.
结论:
- 口服,皮肤上和舌下免疫疗法代表了治疗IgE介导食物过敏的有希望的进展.
- 选择免疫疗法时应考虑个体患者的因素,包括风险耐受性和疗效.
- 提高对这些治疗方案的认识至关重要,因为它们在研究环境之外变得更加容易获得.
相关概念视频
Allergic Reactions
27.3K
Overview
27.3K
Hypersensitivities
573
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
573
Cross-reactivity
31.0K
Overview
31.0K
Allergic Drug Reactions
830
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
830
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
267
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
267

